Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

WORD

HTML

1441

Figures (1-2)

315

Sum=1833

Publishing Process of This Article

Item

Count

Browse

143

Download

349

Sum=492

Aug 6, 2023 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 6, 2023; 11(22): 5309-5315
Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5309

Full Size Figure Download Figure

Figure 2 Patient’s clinical course. TAC: Tacrolimus

Citation: Wang JL, Sun YL, Kang Z, Zhang SK, Yu CX, Zhang W, Xie H, Lin HL. Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report. World J Clin Cases 2023; 11(22): 5309-5315
URL: https://www.wjgnet.com/2307-8960/full/v11/i22/5309.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i22.5309